Study of Safety, Blood Levels and Brain Receptor Occupancy of GSK598809 Using PET Imaging in Health Males.
Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to look at how much of a new drug, GSK598809 binds to specific
proteins in the brain and how much stays in the blood over a range of different doses.